Análise do impacto da pandemia de COVID-19 sobre a atenção a mulheres em situação de aborto na América Latina e Caribe

Autores

DOI:

https://doi.org/10.17566/ciads.v12i4.1024

Palavras-chave:

Gravidez não Planejada, Gravidez na Adolescência, Gravidez não Desejada, Aborto Espontâneo

Resumo

Objetivo: compreender a influência da pandemia de COVID-19 nos aspectos da qualidade da assistência prestada às mulheres em situação de abortamento nos centros sentinela da Rede CLAP-MUSA, uma rede multicêntrica com cooperação internacional visando encorajar boas práticas na América Latina e no Caribe. Metodologia: estudo transversal entre janeiro/2017 e dezembro/2021 com mulheres de qualquer idade admitidas por abortamentos espontâneos ou induzidos. Analisamos o número total de casos e a proporção de abortos legais. As variáveis dependentes foram complicações e uso de anticoncepcionais após o aborto. As variáveis independentes foram a pandemia de COVID-19, dados clínicos e sociodemográficos. A análise estatística foi realizada por meio de regressão linear, regressão múltipla de Poisson, testes de Cochran-Armitage, qui-quadrado, Mann-Whitney e Cohen. Resultados: foram analisados dados de 93.689 mulheres, atendidas em 12 centros sentinelas da Rede CLAP-MUSA, 64,55% no período pré-pandêmico (NP) e 35,45% no período pandêmico (PP) (22,73% receberam atendimento pós-aborto e 77,27%, aborto legal). Não encontramos diferenças no número de casos ao longo do período, independentemente do contexto legal. Observamos um aumento significativo na proporção de abortos legais em contextos liberais e moderados. No NP, 46,46% das mulheres realizaram aborto medicamentoso, enquanto 62,18% das mulheres realizaram aborto medicamentoso no PP (h-Cohen 0,32). Não encontramos aumento no número de complicações durante o PP. No NP, 79,12% iniciaram anticoncepcionais após o aborto, enquanto no PP, 70,39% iniciaram anticoncepcionais após o aborto (h-Cohen 0,20). Conclusão: a pandemia de COVID-19 não se associou à diminuição do número de casos, à diminuição da proporção de interrupções legais ou ao aumento de complicações nos centros sentinelas da Rede CLAP-MUSA.

Submissão: 30/04/23|Revisão: 08/11/23|Aprovação: 09/11/23

Downloads

Os dados de download ainda não estão disponíveis.

Biografia do Autor

  • Rodolfo Gomez Ponce de Leon, Centro Latino-americano de Perinatologia

    Doutor em Saúde Pública, University of North Carolina, Chapel Hill, Carolina do Norte, Estados Unidos; Assessor Regional de Saúde Reprodutiva, Centro Latino-americano de Perinatologia (CLAP), Montevidéo, Uruguai. https://orcid.org/0000-0001-9914-7130. E-mail: gomezr@paho.org

  • Luiz Francisco Baccaro, Universidade Estadual de Campinas

    Doutor; Professor associado, Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brasil. https://orcid.org/0000-0002-8837-8061. E-mail: baccaro@unicamp.br

  • Gonzalo Rubio Schweizer, Universidade de Santiago do Chile

    Médico ginecologista e obstetra, Universidade de Santiago do Chile, Santiago, Chile; Professor assistente, Universidade de Santiago do Chile, Santiago, Chile.  https://orcid.org/0000-0003-0331-6441. E-mail: g.rubiosch@gmail.com

  • Suzanne Jacob Serruya, Centro Latino-americano de Perinatologia

    Doutora em Tocoginecologia, Universidade Estadual de Campinas (UNICAMP), Campinas, São Paulo, Brasil; Diretora, Centro Latino-americano de Perinatologia, Montevidéo, Uruguai. https://orcid.org/0000-0003-1371-4558. E-mail: serruyas@paho.org

Referências

Organização Pan-Americana da Saúde. OMS afirma que COVID-19 é agora caracterizada como pandemia; 11 mar. 2020. [cited in 04/17/2023]. Available at: https://www.paho.org/pt/news/11-3-2020-who-characterizes-covid-19-pandemic

Sachs JD, Karim SSA, Aknin L, et al. The Lancet Commission on lessons for the future from the COVID-19 pandemic. Lancet. 2022 Oct 8;400(10359):1224-1280. Doi https://doi.org/10.1016/S0140-6736(22)01585-9

Cohen MA, Powell AM, Coleman JS, Keller JM, Livingston A, Anderson JR. Special ambulatory gynecologic considerations in the era of coronavirus disease 2019 (COVID-19) and implications for future practice. Am J Obstet Gynecol. 2020 Sep;223(3):372-378. Doi https://doi.org/10.1016/j.ajog.2020.06.006

Spurlin EE, Han ES, Silver ER, et al. Where Have All the Emergencies Gone? The Impact of the COVID-19 Pandemic on Obstetric and Gynecologic Procedures and Consults at a New York City Hospital. J Minim Invasive Gynecol 2021 Jul; 28(7):1411-1419. Doi https://doi.org/10.1016/j.jmig.2020.11.012

Wenham C, Smith J, Davies SE, Feng H, Grépin KA, Harman S, et al. Women are most affected by pandemics —lessons from past outbreaks. Nature 2020 Jul;583(7815):194–198. Doi https://doi.org/10.1038/d41586-020-02006-z

Islam N, Sharp S J, Chowell G, Shabnam S, Kawachi I, Lacey B et al. Physical distancing interventions and incidence of coronavirus disease 2019: natural experiment in 149 countries BMJ 2020 Jul 15; 370:m2743. Doi https://doi.org/10.1136/bmj.m2743

Limb M. Covid-19: Early stage cancer diagnoses fell by third in first lockdown BMJ 2021 May 7; 373:n1179. Doi https://doi.org/10.1136/bmj.n1179

Gajbhiye RK, Sawant MS, Kuppusamy P, et al. Differential impact of COVID-19 in pregnant women from high-income countries and low- to middle-income countries: A systematic review and meta-analysis. Int J Gynaecol Obstet. 2021 Oct;155(1):48-56. Doi https://doi.org/10.1002/ijgo.13793

Gomez Ponce de Leon R, Baccaro LF, Rubio Schweizer G, et al. Building a network of sentinel centres for the care of women in an abortion situation: advances in Latin America and the Caribbean. BMJ Glob Health. 2022 Oct;7(10):e010059. Doi https://doi.org/10.1136/bmjgh-2022-010059

Fescina R, De Mucio B, Martínez G. Sistema Informático perinatal (SIP): historia clínica perinatal: instrucciones de llenado Y definición de términos. Montevideo: CLAP/SMR, 2011.

World Health Organization. Abortion care guideline. Geneva: World Health Organization 2022 [Cited in 04/17/2023]. Available at: https://www.who.int/publications/i/item/9789240039483

Pattinson R, Say L, Souza JP, et al. WHO maternal death and near-miss classifications. Bull World Health Organ. 2009 Oct;87(10):734. Doi https://doi.org/10.2471/BLT.09.071001

Cohen, J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ. Lawrence Earlbaum Associates, 1988.

Polis CB, Biddlecom A, Singh S, et al. Impacts of COVID-19 on contraceptive and abortion services in low- and middle-income countries: a scoping review. Sex Reprod Health Matters. 2022 Dec;30(1):2098557. Doi https://doi.org/10.1080/26410397.2022.2098557

Qaderi K, Khodavirdilou R, Kalhor M, et al. Abortion services during the COVID-19 pandemic: a systematic review. Reprod Health. 2023 Apr 13;20(1):61. Doi https://doi.org/10.1186/s12978-023-01582-3

Cohen MA, Powell AM, Coleman JS, et al. Special ambulatory gynecologic considerations in the era of coronavirus disease 2019 (COVID-19) and implications for future practice. Am J Obstet Gynecol. 2020 Sep;223(3):372-378. Doi https://doi.org/10.1016/j.ajog.2020.06.006

Bayefsky MJ, Bartz D, Watson KL. Abortion during the Covid-19 Pandemic - Ensuring Access to an Essential Health Service. N Engl J Med. 2020 May 7;382(19):e47. Doi https://doi.org/10.1056/NEJMp2008006

IPPF. COVID-19 global impact assessment of IPPF member associations - preliminary analysis and results. IPPF. 2020 [cited in 04/24/2023]. Available at: https://ippf-covid19.org/wpcontent/ uploads/2020/04/Preliminary-results-C-19-MAImpact- survey-April-52.pdf

Chandrasekaran S, Diamond-Smith N, Srinivasan K, Dalvie S. Preparing for an Increased Need for Abortion Access in India during and after COVID-19: Challenges and Strategies. Stud Fam Plann. 2020 Dec;51(4):377-383. Doi https://doi.org/10.1111/sifp.12139

Gichuna S, Hassan R, Sanders T, et al. Access to Healthcare in a time of COVID-19: Sex Workers in Crisis in Nairobi, Kenya. Glob Public Health. 2020 Oct;15(10):1430-1442. Doi https://doi.org/10.1080/17441692.2020.1810298

Vora KS, Saiyed S, Natesan S. Impact of COVID-19 on family planning services in India. Sex Reprod Health Matters. 2020 Dec;28(1):1785378. Doi https://doi.org/10.1080/26410397.2020.1785378

Marquez-Padilla F, Saavedra B. The unintended effects of the COVID-19 pandemic and stay-at-home orders on abortions. J Popul Econ. 2022;35(1):269-305. Doi https://doi.org/10.1007/s00148-021-00874-x

Vora KS, Saiyed S, Natesan S. Impact of COVID-19 on family planning services in India. Sex Reprod Health Matters. 2020 Dec;28(1):1785378. Doi https://doi.org/10.1080/26410397.2020.1785378

VanBenschoten H, Kuganantham H, Larsson EC, et al. Impact of the COVID-19 pandemic on access to and utilisation of services for sexual and reproductive health: a scoping review. BMJ Glob Health. 2022 Oct;7(10):e009594. Doi https://doi.org/10.1136/bmjgh-2022-009594

Endler M, Al-Haidari T, Benedetto C, et al. How the coronavirus disease 2019 pandemic is impacting sexual and reproductive health and rights and response: Results from a global survey of providers, researchers, and policy-makers. Acta Obstet Gynecol Scand. 2021 Apr;100(4):571-578. Doi https://doi.org/10.1111/aogs.14043

Santana DS, Cecatti JG, Parpinelli MA, et al. Severe maternal morbidity due to abortion prospectively identified in a surveillance network in Brazil. Int J Gynaecol Obstet. 2012 Oct;119(1):44-8. Doi https://doi.org/10.1016/j.ijgo.2012.05.025

Upadhyay UD, Desai S, Zlidar V, et al. Incidence of emergency department visits and complications after abortion. Obstet Gynecol. 2015 Jan;125(1):175-183. Doi https://doi.org/10.1097/AOG.0000000000000603

Singh S, Maddow-Zimet I. Facility-based treatment for medical complications resulting from unsafe pregnancy termination in the developing world, 2012: a review of evidence from 26 countries. BJOG. 2016 Aug;123(9):1489-98. Doi https://doi.org/10.1111/1471-0528.13552

von Hertzen H, Piaggio G, Huong NT, et al. Efficacy of two intervals and two routes of administration of misoprostol for termination of early pregnancy: a randomised controlled equivalence trial. Lancet 2007 Jun 9; 369:1938-46. Doi https://doi.org/10.1016/S0140-6736(07)60914-3

Faúndes A, Fiala C, Tang OS, Velasco A. Misoprostol for the termination of pregnancy up to 12 completed weeks of pregnancy. Int J Gynaecol Obstet 2007 Dec; 99 Suppl 2:S172-7. Doi https://doi.org/10.1016/j.ijgo.2007.09.006

Ho PC, Blumenthal PD, Gemzell-Danielsson K, et al. Misoprostol for the termination of pregnancy with a live fetus at 13 to 26 weeks. Int J Gynaecol Obstet 2007 Dec; 99 Suppl 2:S178-81. Doi https://doi.org/10.1016/j.ijgo.2007.09.007

Kaali SG, Szigetvari IA, Bartfai GS. The frequency and management of uterine perforations during first-trimester abortions. Am J Obstet Gynecol 1989 Aug; 161(2):406-8. Doi https://doi.org/10.1016/0002-9378(89)90532-2

Hooker AB, Lemmers M, Thurkow AL, et al. Systematic review and meta-analysis of intrauterine adhesions after miscarriage: prevalence, risk factors and long-term reproductive outcome. Hum Reprod Update 2014 Mar-Apr; 20(2):262-78. Doi https://doi.org/10.1093/humupd/dmt045

De La Vega GA, Nemiroff R, Debbs R. Complications of second-trimester dilation and evacuation. Abstracts of Papers and Posters to be Presented at the ACOG 55th Annual Clinical Meeting, May 5-9, 2007, San Diego, CA. Obstet Gynecol. 2007;109 (Suppl 4):21S. Doi https://doi.org/10.1097/01.AOG.0000254431.11590.f9

Allanson B, Jennings B, Jacques A, et al. Infection and fetal loss in the mid-second trimester of pregnancy. Aust N Z J Obstet Gynaecol. 2010;50(03):221–225. Doi https://doi.org/10.1111/j.1479-828X.2010.01148.x

Conde-Agudelo A, Belizán JM, Lammers C. Maternal-perinatal morbidity and mortality associated with adolescent pregnancy in Latin America: Cross-sectional study. Am J Obstet Gynecol. 2005 Feb;192(2):342-9. Doi https://doi.org/10.1016/j.ajog.2004.10.593

Oliveira FC Jr, Surita FG, Pinto E Silva JL, et al. Severe maternal morbidity and maternal near miss in the extremes of reproductive age: results from a national cross- sectional multicenter study. BMC Pregnancy Childbirth. 2014 Feb 20;14:77. Doi https://doi.org/10.1186/1471-2393-14-77

Araújo TVB, Aquino EML, Menezes GMS, et al. Delays in access to care for abortion-related complications: the experience of women in Northeast Brazil. Cad Saude Publica. 2018 Jun 25;34(6):e00168116. Doi https://doi.org/10.1590/0102-311x00168116

Bearak J, Popinchalk A, Ganatra B, et al. Unintended pregnancy and abortion by income, region, and the legal status of abortion: estimates from a comprehensive model for 1990-2019. Lancet Glob Health. 2020 Sep;8(9):e1152-e1161. Doi https://doi.org/10.1016/S2214-109X(20)30315-6

Schreiber CA, Sober S, Ratcliffe S, Creinin MD. Ovulation resumption after medical abortion with mifepristone and misoprostol. Contraception. 2011 Sep;84:230–233. Doi https://doi.org/10.1016/j.contraception.2011.01.013

Lähteenmäki P, Luukkainen T. Return of ovarian function after abortion. Clin Endocrinol. 1978 Feb;8(2):123–132. Doi https://doi.org/10.1111/j.1365-2265.1978.tb02160.x

Tripney J, Kwan I, Bird KS. Postabortion family planning counseling and services for women in low-income countries: a systematic review. Contraception. 2013 Jan;87(1):17-25. Doi https://doi.org/10.1016/j.contraception.2012.07.014

Fondo de Población de las Naciones Unidas. 8.000 millones de vidas infinitas posibilidades. Argumentos a favor de los derechos y libertades. [cited in 04/26/2023]. Available at: https://www.unfpa.org/es/swp2023

Solo J, Billings DL, Aloo-Obunga C, Ominde A, Makumi M. Creating linkages between incomplete abortion treatment and family planning services in Kenya. Stud Fam Plann. 1999 Mar;30(1):17-27. Doi https://doi.org/10.1111/j.1728-4465.1999.00017.x

Mbehero F, Momanyi R, Hesel K. Facilitating Uptake of Post-abortion Contraception for Young People in Kenya. Front Glob Womens Health. 2022 Jan 20;2:733957. Doi https://doi.org/10.3389/fgwh.2021.733957

Kayi EA, Biney AAE, Dodoo ND, Ofori CAE, Dodoo FN. Women's post-abortion contraceptive use: Are predictors the same for immediate and future uptake of contraception? Evidence from Ghana. PLoS One. 2021 Dec 21;16(12):e0261005. Doi https://doi.org/10.1371/journal.pone.0261005

Downloads

Publicado

27-03-2024

Edição

Seção

ARTIGOS

Como Citar

1.
Análise do impacto da pandemia de COVID-19 sobre a atenção a mulheres em situação de aborto na América Latina e Caribe. Cad. Ibero Am. Direito Sanit. [Internet]. 27º de março de 2024 [citado 18º de maio de 2024];12(4):14-32. Disponível em: https://www.cadernos.prodisa.fiocruz.br/index.php/cadernos/article/view/1024